{"id":"W4252242113","doi":"10.1002/14651858.cd002913","title":"Budesonide for maintenance of remission in Crohn's disease","year":2001,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"","field":"","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Eli Lilly (Canada); GlaxoSmithKline (Canada)","funders":"","keywords":"Budesonide; Medicine; Crohn's disease; Internal medicine; Placebo; Randomized controlled trial; Inflammatory bowel disease; Relative risk; Gastroenterology; Confidence interval; Azathioprine; Clinical trial; Number needed to treat; Maintenance therapy; Disease; Corticosteroid; Chemotherapy; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01018066,0.0007526891,0.006685726,0.004007388,0.0002534977,0.001606135,0.0009527031,0.001605828,0.004749643],"category_scores_gemma":[0.01744859,0.000422254,0.003155909,0.00265603,0.0008212329,0.001313696,0.0005749889,0.001416386,0.0005333879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001345907,"about_ca_system_score_gemma":0.002046211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009882367,"about_ca_topic_score_gemma":0.001922427,"domain_scores_codex":[0.991762,0.004137632,0.002117037,0.0005320721,0.001331919,0.0001191654],"domain_scores_gemma":[0.9858691,0.009733016,0.003721358,0.0001294315,0.0003731002,0.0001740953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.02187779,0.0002001166,0.004196953,0.6380602,0.008452657,0.000376356,0.0001818548,0.0004674845,0.001599374,0.001291063,0.004914594,0.3183816],"study_design_scores_gemma":[0.1249962,0.03017657,0.06816889,0.5429673,0.09128718,0.005174578,0.0005955818,0.001224481,0.004637832,0.003894734,0.1266385,0.0002380524],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004504098,0.9931794,0.0002318006,0.0003596232,0.0002277711,0.0004649744,0.0002470763,0.0000100275,0.0007752723],"genre_scores_gemma":[0.09717607,0.8933504,0.003535859,0.001410693,0.0009502724,0.00176526,0.0006607924,0.00001238048,0.001138175],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01018066,"threshold_uncertainty_score":0.05384117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1506523432794172,"score_gpt":0.413405344603196,"score_spread":0.2627530013237788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}